Directors' Shareholdings

RNS Number : 1042X

Epistem Holdings plc

07 January 2014

 



Epistem Holdings Plc ("Epistem" or the "Company")

Directors' Shareholdings

Epistem today provides an update regarding the Company's share investment plan, details of which were announced on 13 July 2009.

As a result of the subscription for Partnership Shares and the award of Matching Shares, the executive Directors each increased their beneficial interests in the Company by 342 ordinary shares of 1.5p each. These shares were acquired on 28^th October 2013, 28^th November 2013 and 24^th December 2013 at prices of 335p, 330p and 325p respectively.

Following these transactions, the current beneficial interests of the executive Directors are set out below:

                                                Ordinary Shares                       %

Matthew Walls                           10,942                                   0.11%

Dr Catherine Booth                  985,297                                  10.11%

John Rylands                            195,195                                    2.00%

For further details please contact:

Epistem Plc

Matthew Walls, CEO                                                               [phone]

John Rylands, Finance Director                                                 [phone]

Peel Hunt LLP

James Steel /Oliver Jackson                                                      [phone]

 

END

 

 

RDSLLFISLAIDIIS